Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03583424
Title Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ohio State University Comprehensive Cancer Center
Indications

non-Hodgkin lymphoma

Therapies

Carmustine + Cytarabine + Etoposide + Melphalan + Venetoclax

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.